Dr. Reu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
R40
Cleveland, OH 44195Phone+1 216-444-2200
Education & Training
Cleveland Clinic FoundationResidency, Internal Medicine, 2000 - 2003
Eberhard Karls University Faculty of MedicineClass of 1998
Certifications & Licensure
OH State Medical License 2008 - 2026
FL State Medical License 2020 - 2022- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 203 citationsAn open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myelomaRavi Vij, Michael Wang, Jonathan L. Kaufman, Sagar Lonial, Andrzej Jakubowiak
Blood. 2012-06-14 - 496 citationsA phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myelomaDavid S. Siegel, Thomas Martin, Michael Wang, Ravi Vij, Andrzej Jakubowiak
Blood. 2012-10-04 - 600 citationsBortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autolo...Brian G.M. Durie, Antje Hoering, Muneer H. Abidi, S. Vincent Rajkumar, Joshua Epstein
Lancet. 2017-02-04
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
